20th anniversary spotlight

Learn more about the history of innovative research at the Biodesign Institute.

Q&As with center directors

The Biodesign Institute is home to a dynamic group of scientific leaders. Our center directors recruit cutting-edge researchers as well as lead in fields ranging from microbiology and sustainability to molecular science and neuroscience. Explore their profiles to learn more about their groundbreaking work, leadership and contributions to shaping the future of science.

Human microbiomes

Rosa Krajmalnik-Brown is harnessing the power of microbes for human health

Brain health

Jeffrey Kordower’s promising new research for Alzheimer’s and Parkinson’s diseases

Renewable resources

Bruce Rittmann is partnering with microorganisms to enable new technologies

New materials

Timothy Long works toward protecting our planet from plastic pollution

Cellular energy

Sidney Hecht ASU biochemist honored for lifetime achievement in improving human health

DNA sequencing

Stuart Lindsay explores biological molecules at an atomic scale to understand how they function

Computer science

Stephanie Forrest is utilizing a unique integration of computation, biology and health

Protein structure

Petra Fromme is exploring molecules in motion

Health technology

Josh Hihath is revolutionizing health through bioelectronics and biosensors

Cellular evolution

Michael Lynch on understanding evolution at the cellular level

Public health

Rolf Halden is improving human health through environmental monitoring and stewardship

Early diagnostics

Josh LaBaer is transforming health care through personalized medicine

Executive Director Josh LaBaer shares his personal journey as a researcher

Leading extensive interdisciplinary research efforts to solve some of the greatest challenges facing humankind and the planet, Josh LaBaer shares a behind-the-scenes look into his lab, his life and his vision for the institute’s future.

Celebrating ‘20 Years of Discovery’ at the Biodesign Institute

In this series, we revisit several impactful discoveries that have shaped the first two decades of the institute. The Biodesign Institute plays a pivotal role in applying nature-inspired research and technological innovation to address some of the most pressing challenges of our time — translating into tangible benefits for humanity. 

The surprising role of viruses in health and disease

Explore groundbreaking research transforming our understanding of viruses, disease and reproduction.

Read

Evolution and health

Discover our breakthroughs in health science, AI-powered medicine, early disease detection and genetic discoveries.

Read

Transforming health: Biodesign’s diagnostic revolution

The Biodesign Institute is revolutionizing health with cutting-edge diagnostic tools, nanotechnology and innovative plant-based treatments.

Read

Mysteries of the microbiome

How the Biodesign Institute is unlocking revolutionary solutions in microbiome research, structural biology and global health.

Read

Advancements in the multifront battle against cancer

Learn about how the Biodesign Institute is pioneering cancer therapies using oncolytic viruses and other early detection methods, alongside groundbreaking research in clean energy.

Read

Innovating to support Arizona during the COVID-19 pandemic

Looking back at some of the Biodesign Institute’s transformative scientific discoveries.

Read

20 Years of impact

X-ray boon

NSF awards ASU $90.8 million to build first-of-its-kind compact accelerator

2023

Neurodegenerative disease

Research IDs unique hallmarks of six neurogenderative diseases, opening new therapy approaches.

2022

Clean water for spaceflight

Study characterizes different bacterial populations from drinking water from International Space Station.

2021

COVID-19 saliva test

First saliva-based COVID-19 test in the southwestern U.S. to be made widely available to the public

2020

Safer snipping

Researchers develop “immunosilencing” technique, can make CRISPR-Cas9 gene editing safer, more reliable.

2019

Nanobots destroy tumors

Nanobots shrink tumors in first successful study of its kind in mammals.

2017

FDA victory

FDA draws from ASU studies to ban products with antimicrobials, long-term exposure could pose risks.

2016

ASU and Ebola

Workers infected with Ebola virus recover after receiving experimental ZMapp treatment.

2014

FDA OK autism study

Treatment study of children with autism resulted in an 80% reduction of certain symptoms and behavior.

2012

Obesity and gut microbes

Gut microbes may affect weight, study from ASU and Mayo Clinic could become future obesity treatment.

2009

Biodesign opens

A new, collaborative and interdisciplinary institute reflects ASU’s vision for rapid research.

2004